Sartorius’ Post

Reflecting on the 🚧 #milestones and 🧪 #innovations that emerged in 2023, it's evident that this year marked a transformative phase in 🥼 #medical advancements poised to redefine ⛑️ #healthcare and uplift countless lives. From groundbreaking 🧬 #geneediting techniques to personalized #clinicaltrials and #noninvasive 🧑🔬 #diagnostics, these breakthroughs represent promising progress across various 🩺 #medical domains. 1. #CRISPR 🧬 #GeneEditing Revolution: The revolutionary #CRISPR technology unlocked the potential to precisely manipulate and edit human #DNA, offering unprecedented possibilities in treating #geneticdisorders and #diseases. 2. Precision in 🧪 #ClinicalTrials: Embracing genetic profiles in #clinicaltrials signifies a pivotal shift, acknowledging the importance of considering race and #ethnicitybased #geneticvariations in disease susceptibility. This approach promises more tailored and effective #treatments. 3. Paradigm Shift in #CancerDetection: Proximity ligation assays (#PLA) emerged as a #gamechanger in early #cancerdetection, presenting a significant shift in detecting #cancer through protein #biomarker analysis, potentially enabling earlier interventions and improved #outcomes. As we bid farewell to the remarkable year that was 2023, let us carry forward the spirit of #innovation, #hope, and #collaboration into the #NewYear. May the advancements witnessed in the past year continue to propel us towards a future filled with #healthier, more #equitable, and #impactful #medical breakthroughs. Here's to embracing the possibilities of a #brighter and #healthier #tomorrow in the year ahead. Wishing you a joyous and fulfilling New Year!💥✨🎉

Looking back at a very energizing Innovation for Health event yesterday. "The combination of networking, catching up with many relations and making new contacts, and the inspiring lectures was great." - Edwin Van Den Bos My take home messages are: - Research is shifting to disease prevention instead of cure. I really hope that insurance companies and government also support this shift. - Organoids, organised stem cells can be turned into patient-specific models in vitro, which have shown to be predictive for drug sensitivity and specificity for tumor cells. - Sustainability: Pharma has a significant impact on climate change. It was an eye opener for me to see the high contribution of shipping product and samples on dry ice all over the world. Fortunately there are lots of opportunities to decrease carbon footprint. #Progress #LifeSciences #WeAccelerateImprovement

Many of my network colleagues ask me "What is Cytiva?" This is Cytiva ! Cy - comes from CYTO in Greek which means cell. Iva - an ending from Latin that means "doing" and "capable of, something that can (do)". Cells are not only the foundation of all life on Earth. They also hold the potential for transforming the future of healthcare. Check out this short video to learn how Cytiva supports the development of future therapeutics that can help realize our vision of a world in which access to life-changing therapies transforms human health. #lifesciences #innovation #futureofhealthcare

Good example of the growing importance of #partnerships in the market disruption of health care. There isn't one way to disrupt a market, and some of the leading bio-tech and digital companies in U.S. are proving it - the value of good partnerships to grow individual and shared opportunities for all parties. https://lnkd.in/exVC7JDg P.S. For more on this, read our own article on the larger issue of disruption: https://lnkd.in/eMQkp4HR. Jim Bialick

Biotechnology is a fascinating sector where scientific discoveries and cutting-edge innovations are paving the way for a brighter future. Biotech has emerged as a crucial player in healthcare, revolutionizing the way we approach disease prevention, treatment, and management. Check out this article and read about how biotech can push us towards a future that is healthier, more sustainable, and more equitable!

On World Alzheimer’s Day, read how recent developments in the treatment of Alzheimer’s disease are heralding new hope for patients. Portfolio Manager, Linden Thomson, CFA, discusses the potential opportunities for investors amid what could be a game-changing new era for biotech. https://lnkd.in/dWtTCwsv #WorldAlzheimersDay

🔍 Centralized Positioning: Leading The Market & Welcoming New Entrants 🔍 The ever-evolving healthcare landscape demands pioneers who understand the power of centralized positioning. As the CEO of INNOVIA Biobank, I've seen firsthand how a strategic central positioning can not only position you as a market leader but also make new market entries advantageous. Consider the successes of INNOVIA Biobank, INNOVIA GENETICS, and BabyCord Stem Cell Bank. These entities, under the INNOVIA umbrella, have thrived because of our unique centralized positioning. Each brand benefits from shared resources, unified vision, and an ecosystem where innovation is celebrated. But what truly sets us apart is how we view new entrants in the market: 1️⃣ Collaboration Over Competition: We believe in building bridges, not walls. New entrants provide fresh perspectives, leading to a more robust, innovative ecosystem. 2️⃣ Raising Industry Standards: As leaders, we set high benchmarks. New entries often align with or even exceed these benchmarks, pushing the entire industry forward. 3️⃣ Client-Centric Approach: By centralizing our positioning, we’ve been able to provide comprehensive services, setting the gold standard in customer satisfaction. To my peers in the industry: Embrace change, welcome new players, and understand that a centralized positioning can be your secret weapon. The future of healthcare is collaborative, and together, we can create a landscape where everyone thrives. #INNOVIA Biobank #MarketLeadership #CentralizedPositioning

𝐓𝐡𝐞 𝐒𝐨𝐥𝐢𝐝 𝐓𝐮𝐦𝐨𝐫 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐑𝐢𝐬𝐞: 𝐆𝐞𝐭 𝐘𝐨𝐮𝐫 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐄𝐝𝐠𝐞 𝐇𝐞𝐫𝐞 The global #solid_tumor_testing_market is expected to see significant growth at a CAGR of around 8.0% by 2028, driven by factors like: ✅ Increasing adoption of personalized medicine ✅ Rising cancer incidence rates ✅ Technological advancements in tumor testing This trend presents a lucrative opportunity for healthcare professionals and investors alike. 𝐒𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐮𝐫𝐯𝐞 𝐰𝐢𝐭𝐡 MarkNtel Advisors - Market Research Company' 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐨𝐥𝐢𝐝 𝐓𝐮𝐦𝐨𝐫 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (2023-2028): This comprehensive report provides critical insights into: ✅Market #size and #growth forecasts ✅Key market drivers and challenges ✅Competitive landscape ✅Technological advancements ✅And much more! 𝐆𝐞𝐭 𝐚 𝐂𝐨𝐦𝐩𝐥𝐢𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (2024-30)- https://lnkd.in/gV5yDewx 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 - Abbott, ARUP Laboratories, Asuragen, Bio-Rad Laboratories, Guardant Health, Illumina, Invivoscribe, Invitae, Labcorp, NeoGenomics Laboratories, OPKO Health, Inc., OmniSeq, and many more. #health #healthcare #healthcareindustry #solidtumor #cancertesting #personalizedmedicine #marketresearch #marketresearchreports #marketanalysis #marketgrowth #industryanalysis #industrygrowth #consulting #marknteladvisors 

Grateful to have shared the stage with Steffanie Strathdee and Vincent Racaniello a few weeks ago at #SXSW. Here are three messages I am sharing following our #MedicinesGoViral conversation: 1. Viruses historically have been instruments of harm, but we now know they can be leveraged to do some real good in our world as recent development of cell/gene and phage therapies has shown. 2. We need to increase accessibility. There's plenty of room for cell/gene therapies to expand capacity and reduce complexity for broader access to life-saving treatments. 3. Collaboration across the healthcare ecosystem is key to keeping the world (including public policymakers and the #biotech industry) focused on #drugresistance. You can listen to the full conversation here.

Sydney Brenner notes “Progress in science depends on new techniques, new discoveries and new ideas, probably in that order.” New technologies are allowing biotech researchers to dive deeper into their studies and create new solutions to improve human health outcomes. As technology and scientific knowledge continue to advance, I am excited to see a potential shift towards more preventative treatment options that can help healthcare providers get ahead of chronic diseases. #Biotech #EmergingTech #FutureOfBiotech